Please Wait.....
Report
Europe Molecular Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
Market Report I 2026-01-16 I 82 Pages I Mordor Intelligence
Europe Molecular Diagnostics Market Analysis
Europe molecular diagnostics market size in 2026 is estimated at USD 4.09 billion, growing from 2025 value of USD 3.76 billion with 2031 projections showing USD 6.26 billion, growing at 8.84% CAGR over 2026-2031. Adoption of precision-medicine protocols, full enforcement of the In Vitro Diagnostic Regulation (IVDR), and stable funding for antimicrobial-resistance surveillance shape this outlook. Point-of-care (POC) platforms reduce diagnostic turnaround to under an hour, while next-generation sequencing (NGS) moves routine testing from single-gene PCR toward comprehensive genomic profiling. NGS run costs, now below USD 500 per whole exome, make high-throughput sequencing affordable for mid-tier laboratories. Artificial-intelligence (AI) engines that optimize primer and probe design shorten assay-development cycles, attracting venture funding in Germany, the Netherlands, and France. Together, these factors reinforce the Europe molecular diagnostics market as a cornerstone of hospital modernization programs across the region.
Europe Molecular Diagnostics Market Trends and Insights
Rising Adoption of Point-of-Care Molecular Assays
Europe's hospitals now place cartridge-based PCR and isothermal devices in emergency and outpatient units, cutting respiratory-pathogen turnaround from 24 hours to 45 minutes. German tertiary centers report that 60% of emergency departments use POC molecular panels for sepsis triage by 2024. Integrated analyzers upload results directly to electronic records, enabling antibiotic stewardship teams to adjust therapy within a single shift. Scandinavian primary-care clinics pilot near-patient multiplex panels for influenza, RSV, and SARS-CoV-2, reinforcing epidemiologic surveillance. Vendors respond with ruggedized instruments validated for bedside operation, barcoded reagent tracking, and secure cloud dashboards that meet GDPR requirements.
Advances in NGS & Pharmacogenomics Platforms
Sequencing consumable prices dropped 38% between 2023 and 2025, enabling mid-tier labs to offer 500-gene oncology panels under EUR 450 per sample (USD 489). Liquid-biopsy assays detect minimal residual disease months before imaging, prompting therapy adjustments without invasive tissue sampling. The European Medicines Agency now lists 28 companion diagnostics requiring NGS-double the 2022 count-which accelerates test-menu expansion. French payers reimburse CYP450 and DPYD panels, improving antidepressant and fluoropyrimidine safety. Eastern European reference labs outsource bioinformatics to cloud pipelines hosted in Frankfurt and Dublin, bypassing local skill shortages while meeting data-residency rules. Collectively, these factors propel the Europe molecular diagnostics market toward data-rich oncology workflows.
Requirement for High-Complexity Testing Infrastructure
Advanced workflows need ISO 15189 accreditation, biosafety cabinets, and precision thermocyclers-assets scarce outside Western Europe. In 2024, demand for clinical bioinformaticians exceeded supply by 40%, delaying report sign-off in many Eastern European labs. Limited broadband hampers cloud pipelines in rural districts. EU cohesion funds finance upgrades, yet disbursement cycles stretch to five years. These infrastructure gaps temper near-term uptake, moderating the Europe molecular diagnostics market's reach in less-resourced regions.
Other drivers and restraints analyzed in the detailed report include:
Surge in EU-wide Antimicrobial-Resistance Surveillance MandatesIVDR-Driven Demand for CE-IVD Companion DiagnosticsFragmented Payer Reimbursement Across EU-27
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
PCR platforms generated USD 1.47 billion in 2025, equal to 39.12% of the Europe molecular diagnostics market size. Syndromic respiratory and sepsis panels remain anchored in qPCR due to mature workflows. Sequencing outpaces all technologies at a 9.45% CAGR, capturing oncology and infectious-disease tie-outs. Oxford Nanopore's portable sequencers type meningitis pathogens in 45 minutes, encouraging hybrid strategies in which rapid PCR rules out common infections and on-demand NGS clarifies resistance profiles. Mass spectrometry and microarrays retain niches, but AI-enabled reagent design increasingly blurs platform borders, deepening vendor competition across the Europe molecular diagnostics market.
Infectious disease assays produced USD 1.73 billion in 2025, or 46.10% of the Europe molecular diagnostics market size. Multiplex panels detect 20+ pathogens per sample, reducing sequential testing. Whole-genome sequencing traces hospital outbreaks, feeding infection-control dashboards. Oncology assays grow at 9.52% CAGR, driven by liquid biopsy and targeted therapy selection. Pharmacogenomics panels cross into psychiatry and cardiology, though payer support lags in Southern Europe. Expanded newborn-screening programs push genetic-disease testing, while antimicrobial-resistance assays integrate qPCR with sequencing to oversee surveillance.
The Europe Molecular Diagnostics Market Report is Segmented by Technology (In Situ Hybridization, and More), Application (Infectious Disease Diagnostics, and More), Product (Instruments & Analysers, and More), End-User (Hospitals, and More), Sample Type (Blood, and More), Test Setting (Centralised Laboratories, and More), and Geography (Germany, and More). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Abbott Laboratories Agilent Technologies Beckton Dickinson bioMerieux Biocartis NV Cepheid (Danaher) Danaher Corporation (Beckman, Leica, Cepheid) Eurofins Roche GenMark Diagnostics Hologic Illumina Luminex (DiaSorin) Myriad Genetics Oxford Nanopore Technologies QIAGEN Seegene Siemens Healthineers Sysmex Thermo Fisher Scientific T2 Biosystems
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Adoption of Point-of-care (POC) Molecular Assays
4.2.2 Advances in NGS & Pharmacogenomics Platforms
4.2.3 Surge in EU-wide Antimicrobial-resistance Surveillance Mandates
4.2.4 IVDR-driven Demand for CE-IVD Companion Diagnostics
4.2.5 Growth of AI-assisted Primer/probe Design Startups
4.3 Market Restraints
4.3.1 Requirement for High-complexity Testing Infrastructure
4.3.2 Fragmented Payer Reimbursement Across EU-27
4.3.3 Shortage of Certified Molecular-bioinformaticians
4.3.4 GDPR-related Restrictions on Cross-border Sample Transfer
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Bargaining Power of Buyers/Consumers
4.7.2 Bargaining Power of Suppliers
4.7.3 Threat of New Entrants
4.7.4 Threat of Substitute Products
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value - USD)
5.1 By Technology
5.1.1 In Situ Hybridization
5.1.2 Chips and Microarrays
5.1.3 Mass Spectrometry (MS)
5.1.4 Sequencing
5.1.5 PCR
5.1.6 Other Technologies
5.2 By Application
5.2.1 Infectious Disease Diagnostics
5.2.2 Oncology & Liquid Biopsy
5.2.3 Pharmacogenomics
5.2.4 Genetic Disease Testing
5.2.5 Microbiology & Antimicrobial-Resistance
5.2.6 Other Applications
5.3 By Product
5.3.1 Instruments & Analysers
5.3.2 Reagents & Kits
5.3.3 Software & Services
5.4 By End-user
5.4.1 Hospitals & Hospital Labs
5.4.2 Independent Reference Laboratories
5.4.3 Point-of-Care / Near-Patient Settings
5.4.4 Academic & Research Institutes
5.5 By Sample Type
5.5.1 Blood / Plasma
5.5.2 Tissue / FFPE
5.5.3 Saliva & Buccal Swab
5.5.4 Urine & Other Body Fluids
5.6 By Test Setting
5.6.1 Centralised Laboratories
5.6.2 Decentralised / POC Sites
5.7 By Country
5.7.1 Germany
5.7.2 United Kingdom
5.7.3 France
5.7.4 Italy
5.7.5 Spain
5.7.6 Rest of Europe
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Abbott Laboratories
6.3.2 Agilent Technologies
6.3.3 Becton, Dickinson and Company
6.3.4 bioMerieux SA
6.3.5 Biocartis NV
6.3.6 Cepheid (Danaher)
6.3.7 Danaher Corporation (Beckman, Leica, Cepheid)
6.3.8 Eurofins Scientific
6.3.9 F. Hoffmann-La Roche Ltd
6.3.10 GenMark Diagnostics
6.3.11 Hologic Inc.
6.3.12 Illumina Inc.
6.3.13 Luminex (DiaSorin)
6.3.14 Myriad Genetics
6.3.15 Oxford Nanopore Technologies
6.3.16 QIAGEN N.V.
6.3.17 Seegene Inc.
6.3.18 Siemens Healthineers
6.3.19 Sysmex Corporation
6.3.20 Thermo Fisher Scientific
6.3.21 T2 Biosystems
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security